Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Pantoprazole Dosing Comparison in Healthy Volunteers
NCT01499693Phase 3Withdrawn
- Sponsor
- Takeda
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Panzobax in gastroesophageal reflux disease (GERD), sponsored by Takeda. Status: withdrawn.
02
Drugs
Panzobax
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01499693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499693.